Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription 14.09.2026 5 Allergy 1 Am J Respir Crit Care Med 2 Ann Allergy Asthma Immunol 5 Chest 1 Clin Exp Allergy 1 Curr Opin Pulm Med 2 Eur Respir J 1 J Allergy Clin Immunol 7 J Asthma 1 J Investig Allergol Clin Immunol 1 Lancet 1 Pediatrics 1 PLoS Med 2 PLoS One 13 Respir Med 1 Respir Res 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Allergy

1. LEE H, Heo J, Nam J, Kang S, et al
   Cumulative Vulnerability to Particulate Matter and Incident Asthma: Joint Effects of Urbanicity, Poverty, and Age in a Nationwide Cohort.
   Allergy. 2026 Sep 11. doi: 10.1111/all.70502.
   PubMed         Abstract available
   
   
2. WECHSLER ME, Akuthota P, Quart B, Collazo R, et al
   Rademikibart for Asthma With Type 2 Biomarkers: Exploratory Subgroup Analyses From a Phase 2b Randomized Clinical Trial.
   Allergy. 2026 Sep 9. doi: 10.1111/all.70506.
   PubMed         Abstract available
   
   
3. JAKWERTH CA, Illi S, Charles H, Oelsner M, et al
   Nasal Epithelial Immune Signatures Are Associated With Age-Dependent Asthma Trajectories in Early Life.
   Allergy. 2026 Sep 6. doi: 10.1111/all.70477.
   PubMed         Abstract available
   
   
4. BROSTROM L, Bergstrom A, Merritt AS, Odling M, et al
   Asthma Remission From Childhood to Young Adulthood-A Population-Based Cohort Study.
   Allergy. 2026 Sep 6. doi: 10.1111/all.70496.
   PubMed         Abstract available
   
   
5. DECLERCQ J, Aegerter H, Smole U, Van Damme KFA, et al
   Chitin Is a Potent Inducer of Type 2 Airway Inflammation Independent of Endogenous Chitinolytic Activity.
   Allergy. 2026;81:3328-3344.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

6. NARAYANA JK, Jaggi TK, Dimakou K, Ivan FX, et al
   Pseudomonas Aeruginosa Abundotypes and Interactotypes Reflect Clinical Heterogeneity in Bronchiectasis.
   Am J Respir Crit Care Med. 2026 Sep 11:aamag464. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Allergy Asthma Immunol

7. LIAN D, Lin C, Wei J, Tang Q, et al
   Household food hardship and asthma morbidity among United States children with current asthma.
   Ann Allergy Asthma Immunol. 2026 Sep 12:S1081-1206(26)00450.
   PubMed         Abstract available
   
   
8. YOSHIZATO R, Motomura Y, Fujita T, Babazono A, et al
   Corrigendum to 'Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection' [Annals of Allergy, Asthma & Immunology. Volumne 132, Issue 2 (2024), Pages 240-242].
   Ann Allergy Asthma Immunol. 2026 Sep 11:S1081-1206(26)00440.
   PubMed        
   
   

   
   Chest

9. WU F, Wan Q, Tian H, Zheng Y, et al
   Prognostic Significance of Mild Exacerbations or 1 Moderate Exacerbation in COPD: A Prospective Community-Based Cohort Study.
   Chest. 2026;170:725-738.
   PubMed         Abstract available
   
   
10. REVEL MP, Goo JM, Vliegenthart R, Silva M, et al
    Smoking-Related Comorbidities Detected Through Low-dose CT Lung Cancer Screening: Current Evidence and Future Directions.
    Chest. 2026 May 29:S0012-3692(26)00761-0. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    
11. CANONICA GW, Christoff GC, Tsai MJ, Tran TN, et al
    Assessing the impact of earlier initiation of biologics on clinical remission and other outcomes in a global real-life severe asthma cohort from CHRONICLE, ISAR and OPCRD.
    Chest. 2026 Sep 9:S0012-3692(26)06552-9. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    
12. CAZZOLA M, Matera MG
    Biologics for Asthma and COPD Exacerbations: Conceptual Rationale and Clinical Uncertainty.
    Chest. 2026;170:669-671.
    PubMed        
    
    
13. STOLLER JK
    Liver Transplantation Prevents Emphysema Progression in Alpha-1.
    Chest. 2026;170:e105-e106.
    PubMed        
    
    

    
    Clin Exp Allergy

14. SHIH PC, Lin CT, Wei JCC
    Cardiovascular Outcomes With Dupilumab Versus Omalizumab in Severe Asthma.
    Clin Exp Allergy. 2026 Sep 6. doi: 10.1111/cea.70413.
    PubMed        
    
    

    
    Curr Opin Pulm Med

15. FLOWERS RC, Chablaney S, Basavaraj A
    Reflux in bronchiectasis: current evidence and clinical implications.
    Curr Opin Pulm Med. 2026 Sep 9. doi: 10.1097/MCP.0000000000001309.
    PubMed         Abstract available
    
    

    
    Eur Respir J

16. YAO P, Yang L, Liu D, He D, et al
    Distribution of blood eosinophil counts in the Chinese general population.
    Eur Respir J. 2026;68:2501570.
    PubMed         Abstract available
    
    
17. OTUNLA AA, Shanmugarajah K, Mukhtar G, Nabulsi S, et al
    The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis.
    Eur Respir J. 2026;68:2501890.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

18. SMITH MJ, Kulagin M, Iglesias AH, Bieren JE, et al
    Spatial eicosanoid mapping localizes prostaglandin E(2) shifts in the lung during severe (experimental) asthma.
    J Allergy Clin Immunol. 2026 Sep 9:S0091-6749(26)00592.
    PubMed        
    
    

    
    J Asthma

19. HOJ S, Meteran H
    Biologic-assisted house dust mite immunotherapy in allergic asthma: could it provide a bridge toward de-escalation?
    J Asthma. 2026 Sep 7:1-3. doi: 10.1080/02770903.2026.2730877.
    PubMed        
    
    
20. MUHAMMAD HUSSAIN J, Abdul Rehman MB, Shah SH, Chawla R, et al
    Asthma in College Hostels: Unrecognized Psychosocial Burdens and Management Deficits.
    J Asthma. 2026 Sep 6:1-7. doi: 10.1080/02770903.2026.2730889.
    PubMed         Abstract available
    
    
21. SENCAN ED, Ozdogan S, Yolsal F, Kaya A, et al
    Recovery patterns of pulmonary function after acute asthma exacerbation in children: a prospective study using time-to-event analysis.
    J Asthma. 2026 Sep 6:1-12. doi: 10.1080/02770903.2026.2730887.
    PubMed         Abstract available
    
    
22. BUTT A, Qureshi S, Tanveer N, Hussain N, et al
    Inhaled corticosteroids with short-acting beta(2)-agonists as rescue therapy for asthma: a systematic review and meta-analysis of randomized controlled trials.
    J Asthma. 2026 Sep 8:1-9. doi: 10.1080/02770903.2026.2730882.
    PubMed         Abstract available
    
    
23. CATAK S, Acar Tek N
    Mediterranean diet in obese children with asthma: a single-arm pilot study.
    J Asthma. 2026 Sep 10:1-12. doi: 10.1080/02770903.2026.2730884.
    PubMed         Abstract available
    
    
24. YALIM SA, Celik GE
    Beyond the Clinical Snapshot: Integrating Phenotypic Nuances and Socio-Environmental Barriers into the National Asthma Landscape.
    J Asthma. 2026 Sep 8:1-5. doi: 10.1080/02770903.2026.2730880.
    PubMed        
    
    
25. HARMAN E, Colkesen F, Emin Gerek M, Sagun F, et al
    Phenotypic Predictors of Response to IL-5 Pathway Inhibitors in Severe Eosinophilic Asthma: A Retrospective Real-World Cohort.
    J Asthma. 2026 Sep 11:1-13. doi: 10.1080/02770903.2026.2730874.
    PubMed         Abstract available
    
    

    
    J Investig Allergol Clin Immunol

26. AUSIN P, Parrilla F, Torres Boso P, Navarrete Rouco E, et al
    Immunologic Effects of Tezepelumab in Rhinovirus-Triggered Near-Fatal Asthma.
    J Investig Allergol Clin Immunol. 2026 Sep 7:0. doi: 10.18176/jiaci.1204.
    PubMed        
    
    

    
    Lancet

27. JADDOE VWV, Duijts L
    Early-life primary prevention of childhood asthma.
    Lancet. 2026 Sep 7:S0140-6736(26)01769-1. doi: 10.1016/S0140-6736(26)01769.
    PubMed        
    
    

    
    Pediatrics

28. GEISSLER KH, Shieh MS, Poronsky KE, Lindenauer PK, et al
    Medicaid ACO Implementation and Pediatric Asthma Care Equity.
    Pediatrics. 2026 Sep 9:e2025074217. doi: 10.1542/peds.2025-074217.
    PubMed         Abstract available
    
    

    
    PLoS Med

29. LENGLART L, Titomanlio L, Alberti I, Almeida L, et al
    Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.
    PLoS Med. 2026;23:e1005223.
    PubMed         Abstract available
    
    

    
    PLoS One

30. PU W, Zhang M, Guo S, Bao X, et al
    miR-191 affects skeletal muscle differentiation by regulating Wwp1 in mouse myoblasts.
    PLoS One. 2026;21:e0355370.
    PubMed         Abstract available
    
    
31. COLAKOGLU C, Ozsahin SL
    Inflammatory discordance phenotype in COPD: Dissociation between neutrophil-to-lymphocyte ratio and conventional markers.
    PLoS One. 2026;21:e0357923.
    PubMed         Abstract available
    
    

    
    Respir Med

32. OTARU AJ, Abubakar FZ, Ibitoye MO
    Breathing life into data: A critical review of artificial intelligence and computational modelling in COPD precision management.
    Respir Med. 2026;262:109121.
    PubMed         Abstract available
    
    
33. ZHOU K, Wu F, Wan Q, Tang G, et al
    Association between respiratory exacerbations and accelerated lung function decline in chronic obstructive pulmonary disease: a prospective observational population-based cohort study.
    Respir Med. 2026;262:109110.
    PubMed         Abstract available
    
    
34. JOO H, Park S, Jang JG, Lee H, et al
    Post-bronchodilator FEF(25-75) and COPD exacerbations: The role of airflow obstruction severity in the KOCOSS cohort.
    Respir Med. 2026;262:109108.
    PubMed         Abstract available
    
    
35. LAIRD P, Wedderburn I, Wray E, Dempsey Z, et al
    Advancing equity: six-year respiratory outcomes in young Indigenous children following early respiratory disease detection.
    Respir Med. 2026;262:109103.
    PubMed         Abstract available
    
    
36. BARTZIOKAS K, Glynos C, Papaioannou AI
    Viewpoint: Pathway-sensitive eligibility for biologic therapy in COPD: The role of primary care, phenotyping, and eosinophil-guided management.
    Respir Med. 2026;262:109083.
    PubMed         Abstract available
    
    
37. PAPI A, Han MK, Rogliani P, Wedzicha JA, et al
    COPD case finding and identification of at-risk individuals: opportunities for early personalized intervention and disease interception.
    Respir Med. 2026;262:109080.
    PubMed         Abstract available
    
    
38. SANGWAN P, Sharma JG, Habib MA, Alam MI, et al
    Oxidative stress-driven dysregulation of the MMP-2/TIMP-2 axis in chronic obstructive pulmonary disease: Molecular mechanisms, genetic polymorphisms, and therapeutic implications.
    Respir Med. 2026;262:109084.
    PubMed         Abstract available
    
    
39. VENKITAKRISHNAN R, Vora A, Thomas PK, Bansal A, et al
    Targeting chronic mucus hypersecretion in respiratory diseases - focus on OPEP devices.
    Respir Med. 2026;262:109085.
    PubMed         Abstract available
    
    
40. CORTES-TELLES A, Schaeffer MR, Figueroa-Hurtado E, Ortiz-Farias DL, et al
    Comparison of GLI-Global and PLATINO spirometry equations for disease identification and staging in a Mexican-Hispanic population.
    Respir Med. 2026;262:109087.
    PubMed         Abstract available
    
    
41. SINGH D, Poggesi I, Weng S, Slade D, et al
    Developing low-carbon metered-dose inhalers: effects of propellant HFA-152a on mucociliary clearance and bronchoconstriction in two Phase 1 randomised trials.
    Respir Med. 2026;262:109053.
    PubMed         Abstract available
    
    
42. KUMAR A, Das S, Koirala N, Khatua D, et al
    Integrating CBC-derived inflammatory biomarkers with machine learning for discriminating stable and exacerbated COPD.
    Respir Med. 2026;262:109118.
    PubMed         Abstract available
    
    
43. LEE HW, Kim DK, Um SJ, Park SJ, et al
    Prolonged smoking duration is independently associated with mortality in former smokers with COPD regardless of pack-years.
    Respir Med. 2026;262:109128.
    PubMed         Abstract available
    
    
44. SCICHILONE N, Genduso G, Bagnasco D, Barone A, et al
    Corrigendum to "Adherence to inhaled treatment is associated with better disease control and quality of life in mild-to-moderate asthma" [Respir. Med. 262, (2026), 109127].
    Respir Med. 2026 Sep 10:109153. doi: 10.1016/j.rmed.2026.109153.
    PubMed        
    
    

    
    Respir Res

45. RITZMANN F, Brand M, Gasparoni G, Zhang X, et al
    Current smoking and COPD are associated with differentiation-dependent secretory and inflammatory programs in airway basal cells.
    Respir Res. 2026;27:343.
    PubMed         Abstract available
    
    

    
    Thorax

46. LEILY M, Arshad SH
    Beyond the snapshot: childhood immune trajectories and the evolving asthma syndrome.
    Thorax. 2026 Sep 9:thorax-2026-225644. doi: 10.1136/thorax-2026-225644.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum